SCHEMBL15213173

SCHEMBL15213173

COCC1(CNC=O)CC1

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 1/20 0.30
ADH1A P07327 1/20 0.30
ADH7 P40394 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24920795 0.92
SCHEMBL24922076 0.92 KDM1A (0.31)
SCHEMBL24922079 0.90 ADH1B (0.31) ADH1BADH1AADH7
SCHEMBL24920710 0.74 KDM1A (0.36)
SCHEMBL14175035 0.73
SCHEMBL20678803 0.71
Hydrochloric Acid SCHEMBL19086630 0.71 PRMT3 (0.31)
SCHEMBL7875657 0.71
SCHEMBL15200485 0.69 TSHR (0.38)
SCHEMBL23434537 0.68 KDM1A (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023006097-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER 海创药业股份有限公司 2023-02-02 WO disclosed
WO-2013120980-A1 TRICYCLIC COMPOUNDS AND METHODS OF USE THEREFOR F. HOFFMANN-LA ROCHE AG (CH) 2013-08-22 WO disclosed